<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27630238</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>90</Volume><Issue>23</Issue><PubDate><Year>2016</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>SUMO Modification Stabilizes Enterovirus 71 Polymerase 3D To Facilitate Viral Replication.</ArticleTitle><Pagination><StartPage>10472</StartPage><EndPage>10485</EndPage><MedlinePgn>10472-10485</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.01756-16</ELocationID><Abstract><AbstractText Label="UNLABELLED">Accumulating evidence suggests that viruses hijack cellular proteins to circumvent the host immune system. Ubiquitination and SUMOylation are extensively studied posttranslational modifications (PTMs) that play critical roles in diverse biological processes. Cross talk between ubiquitination and SUMOylation of both host and viral proteins has been reported to result in distinct functional consequences. Enterovirus 71 (EV71), an RNA virus belonging to the family Picornaviridae, is a common cause of hand, foot, and mouth disease. Little is known concerning how host PTM systems interact with enteroviruses. Here, we demonstrate that the 3D protein, an RNA-dependent RNA polymerase (RdRp) of EV71, is modified by small ubiquitin-like modifier 1 (SUMO-1) both during infection and in vitro Residues K159 and L150/D151/L152 were responsible for 3D SUMOylation as determined by bioinformatics prediction combined with site-directed mutagenesis. Also, primer-dependent polymerase assays indicated that mutation of SUMOylation sites impaired 3D polymerase activity and virus replication. Moreover, 3D is ubiquitinated in a SUMO-dependent manner, and SUMOylation is crucial for 3D stability, which may be due to the interplay between the two PTMs. Importantly, increasing the level of SUMO-1 in EV71-infected cells augmented the SUMOylation and ubiquitination levels of 3D, leading to enhanced replication of EV71. These results together suggested that SUMO and ubiquitin cooperatively regulated EV71 infection, either by SUMO-ubiquitin hybrid chains or by ubiquitin conjugating to the exposed lysine residue through SUMOylation. Our study provides new insight into how a virus utilizes cellular pathways to facilitate its replication.</AbstractText><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Infection with enterovirus 71 (EV71) often causes neurological diseases in children, and EV71 is responsible for the majority of fatalities. Based on a better understanding of interplay between virus and host cell, antiviral drugs against enteroviruses may be developed. As a dynamic cellular process of posttranslational modification, SUMOylation regulates global cellular protein localization, interaction, stability, and enzymatic activity. However, little is known concerning how SUMOylation directly influences virus replication by targeting viral polymerase. Here, we found that EV71 polymerase 3D was SUMOylated during EV71 infection and in vitro Moreover, the SUMOylation sites were determined, and in vitro polymerase assays indicated that mutations at SUMOylation sites could impair polymerase synthesis. Importantly, 3D is ubiquitinated in a SUMOylation-dependent manner that enhances the stability of the viral polymerase. Our findings indicate that the two modifications likely cooperatively enhance virus replication. Our study may offer a new therapeutic strategy against virus replication.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016, American Society for Microbiology. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Zhenhua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China zhengzh@wh.iov.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shu</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Caishang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ke</LastName><ForeName>Xianliang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Qinxue</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hanzhong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.48</RegistryNumber><NameOfSubstance UI="D012324">RNA-Dependent RNA Polymerase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004795" MajorTopicYN="N">Enzyme Stability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016297" MajorTopicYN="N">Mutagenesis, Site-Directed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012324" MajorTopicYN="N">RNA-Dependent RNA Polymerase</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058207" MajorTopicYN="N">Sumoylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054875" MajorTopicYN="N">Ubiquitination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>5</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27630238</ArticleId><ArticleId IdType="pmc">PMC5110190</ArticleId><ArticleId IdType="doi">10.1128/JVI.01756-16</ArticleId><ArticleId IdType="pii">JVI.01756-16</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Meulmeester E, Melchior F. 2008. Cell biology: SUMO. Nature 452:709&#x2013;711. doi:10.1038/452709a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/452709a</ArticleId><ArticleId IdType="pubmed">18401402</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayer P, Arndt A, Metzger S, Mahajan R, Melchior F, Jaenicke R, Becker J. 1998. Structure determination of the small ubiquitin-related modifier SUMO-1. J Mol Biol 280:275&#x2013;286. doi:10.1006/jmbi.1998.1839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1998.1839</ArticleId><ArticleId IdType="pubmed">9654451</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatham MH, Jaffray E, Vaughan OA, Desterro JMP, Botting CH, Naismith JH, Hay RT. 2001. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J Biol Chem 276:35368&#x2013;35374. doi:10.1074/jbc.M104214200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M104214200</ArticleId><ArticleId IdType="pubmed">11451954</ArticleId></ArticleIdList></Reference><Reference><Citation>Bylebyl GR, Belichenko I, Johnson ES. 2003. The SUMO isopeptidase Ulp2 prevents accumulation of SUMO chains in yeast. J Biol Chem 278:44113&#x2013;44120. doi:10.1074/jbc.M308357200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M308357200</ArticleId><ArticleId IdType="pubmed">12941945</ArticleId></ArticleIdList></Reference><Reference><Citation>Matic I, van Hagen M, Schimmel J, Macek B, Ogg SC, Tatham MH, Hay RT, Lamond AI, Mann M, Vertegaal ACO. 2008. In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Mol Cell Proteomics 7:132&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3840926</ArticleId><ArticleId IdType="pubmed">17938407</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YG, Dasso M. 2009. SUMOylation and deSUMOylation at a glance. J Cell Sci 122:4249&#x2013;4252. doi:10.1242/jcs.050542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.050542</ArticleId><ArticleId IdType="pmc">PMC2779127</ArticleId><ArticleId IdType="pubmed">19923268</ArticleId></ArticleIdList></Reference><Reference><Citation>Everett RD, Boutell C, Hale BG. 2013. Interplay between viruses and host sumoylation pathways. Nat Rev Microbiol 11:400&#x2013;411. doi:10.1038/nrmicro3015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro3015</ArticleId><ArticleId IdType="pubmed">23624814</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay RT. 2007. SUMO-specific proteases: a twist in the tail. Trends Cell Biol 17:370&#x2013;376. doi:10.1016/j.tcb.2007.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2007.08.002</ArticleId><ArticleId IdType="pubmed">17768054</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson ES, Blobel G. 1997. Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J Biol Chem 272:26799&#x2013;26802. doi:10.1074/jbc.272.43.26799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.272.43.26799</ArticleId><ArticleId IdType="pubmed">9341106</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi T, Seki M, Maeda D, Wang WS, Kawabe Y, Seki T, Saitoh H, Fukagawa T, Yagi H, Enomoto T. 2002. Ubc9 is essential for viability of higher eukaryotic cells. Exp Cell Res 280:212&#x2013;221. doi:10.1006/excr.2002.5634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/excr.2002.5634</ArticleId><ArticleId IdType="pubmed">12413887</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernier-Villamor V, Sampson DA, Matunis MJ, Lima CD. 2002. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell 108:345&#x2013;356. doi:10.1016/S0092-8674(02)00630-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(02)00630-X</ArticleId><ArticleId IdType="pubmed">11853669</ArticleId></ArticleIdList></Reference><Reference><Citation>Gareau JR, Lima CD. 2010. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat Rev Mol Cell Biol 11:861&#x2013;871. doi:10.1038/nrm3011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3011</ArticleId><ArticleId IdType="pmc">PMC3079294</ArticleId><ArticleId IdType="pubmed">21102611</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay RT. 2005. SUMO: a history of modification. Mol Cell 18:1&#x2013;12. doi:10.1016/j.molcel.2005.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2005.03.012</ArticleId><ArticleId IdType="pubmed">15808504</ArticleId></ArticleIdList></Reference><Reference><Citation>Merrill JC, Melhuish TA, Kagey MH, Yang SH, Sharrocks AD, Wotton D. 2010. A role for non-covalent SUMO interaction motifs in Pc2/CBX4 E3 activity. PLoS One 5:e8794. doi:10.1371/journal.pone.0008794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0008794</ArticleId><ArticleId IdType="pmc">PMC2808386</ArticleId><ArticleId IdType="pubmed">20098713</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J, Durrin LK, Wilkinson TA, Krontiris TG, Chen Y. 2004. Identification of a SUMO-binding motif that recognizes SUMO modified proteins. Proc Natl Acad Sci U S A 101:14373&#x2013;14378. doi:10.1073/pnas.0403498101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0403498101</ArticleId><ArticleId IdType="pmc">PMC521952</ArticleId><ArticleId IdType="pubmed">15388847</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J, Zhang ZM, Hu WD, Chen Y. 2005. Small ubiquitin-like modifier (SUMO) recognition of a SUMO binding motif: a reversal of the bound orientation. J Biol Chem 280:40122&#x2013;40129. doi:10.1074/jbc.M507059200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M507059200</ArticleId><ArticleId IdType="pubmed">16204249</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun HY, Hunter T. 2012. Poly-small ubiquitin-like modifier (PolySUMO)-binding proteins identified through a string search. J Biol Chem 287:42071&#x2013;42083. doi:10.1074/jbc.M112.410985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.410985</ArticleId><ArticleId IdType="pmc">PMC3516753</ArticleId><ArticleId IdType="pubmed">23086935</ArticleId></ArticleIdList></Reference><Reference><Citation>Kravtsova-Ivantsiv Y, Ciechanover A. 2012. Non-canonical ubiquitin-based signals for proteasomal degradation. J Cell Sci 125:539&#x2013;548. doi:10.1242/jcs.093567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.093567</ArticleId><ArticleId IdType="pubmed">22389393</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzzo CM, Matunis MJ. 2013. Expanding SUMO and ubiquitin-mediated signaling through hybrid SUMO-ubiquitin chains and their receptors. Cell Cycle 12:1015&#x2013;1017. doi:10.4161/cc.24332.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.24332</ArticleId><ArticleId IdType="pmc">PMC3646854</ArticleId><ArticleId IdType="pubmed">23511166</ArticleId></ArticleIdList></Reference><Reference><Citation>Praefcke GJK, Hofmann K, Dohmen J. 2012. SUMO playing tag with ubiquitin. Trends Biochem Sci 37:23&#x2013;31. doi:10.1016/j.tibs.2011.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2011.09.002</ArticleId><ArticleId IdType="pubmed">22018829</ArticleId></ArticleIdList></Reference><Reference><Citation>Denuc A, Marfany G. 2010. SUMO and ubiquitin paths converge. Biochem Soc Trans 38:34&#x2013;39. doi:10.1042/BST0380034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST0380034</ArticleId><ArticleId IdType="pubmed">20074031</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattoscio D, Segre CV, Chiocca S. 2013. Viral manipulation of cellular protein conjugation pathways: the SUMO lesson. World J Virol 2:79&#x2013;90. doi:10.5501/wjv.v2.i2.79.</Citation><ArticleIdList><ArticleId IdType="doi">10.5501/wjv.v2.i2.79</ArticleId><ArticleId IdType="pmc">PMC3785051</ArticleId><ArticleId IdType="pubmed">24175232</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevels M, Brune W, Shenk T. 2004. SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication. J Virol 78:7803&#x2013;7812. doi:10.1128/JVI.78.14.7803-7812.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.14.7803-7812.2004</ArticleId><ArticleId IdType="pmc">PMC434104</ArticleId><ArticleId IdType="pubmed">15220454</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann H, Floss S, Stamminger T. 2000. Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b. J Virol 74:2510&#x2013;2524. doi:10.1128/JVI.74.6.2510-2524.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.6.2510-2524.2000</ArticleId><ArticleId IdType="pmc">PMC111739</ArticleId><ArticleId IdType="pubmed">10684265</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinigalia E, Alvisi G, Segre CV, Mercorelli B, Muratore G, Winkler M, Hsiao HH, Urlaub H, Ripalti A, Chiocca S, Palu G, Loregian A. 2012. The human cytomegalovirus DNA polymerase processivity factor UL44 is modified by SUMO in a DNA-dependent manner. PLoS One 7:e49630. doi:10.1371/journal.pone.0049630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0049630</ArticleId><ArticleId IdType="pmc">PMC3499415</ArticleId><ArticleId IdType="pubmed">23166733</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim ET, Kim YE, Huh YH, Ahn JH. 2010. Role of noncovalent SUMO binding by the human cytomegalovirus IE2 transactivator in lytic growth. J Virol 84:8111&#x2013;8123. doi:10.1128/JVI.00459-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00459-10</ArticleId><ArticleId IdType="pmc">PMC2916544</ArticleId><ArticleId IdType="pubmed">20519406</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal S, Santos A, Rosas JM, Ortiz-Guzman J, Rosas-Acosta G. 2011. Influenza A virus interacts extensively with the cellular SUMOylation system during infection. Virus Res 158:12&#x2013;27. doi:10.1016/j.virusres.2011.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2011.02.017</ArticleId><ArticleId IdType="pubmed">21376763</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu K, Klenk C, Liu B, Keiner B, Cheng J, Zheng BJ, Li L, Han Q, Wang C, Li T, Chen Z, Shu Y, Liu J, Klenk HD, Sun B. 2011. Modification of nonstructural protein 1 of influenza A virus by SUMO1. J Virol 85:1086&#x2013;1098. doi:10.1128/JVI.00877-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00877-10</ArticleId><ArticleId IdType="pmc">PMC3020006</ArticleId><ArticleId IdType="pubmed">21047957</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CY, Jeng KS, Lai MM. 2011. The SUMOylation of matrix protein M1 modulates the assembly and morphogenesis of influenza A virus. J Virol 85:6618&#x2013;6628. doi:10.1128/JVI.02401-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02401-10</ArticleId><ArticleId IdType="pmc">PMC3126537</ArticleId><ArticleId IdType="pubmed">21507966</ArticleId></ArticleIdList></Reference><Reference><Citation>Han QL, Chang C, Li L, Klenk C, Cheng JK, Chen YX, Xia NS, Shu YL, Chen Z, Gabriel G, Sun B, Xu K. 2014. Sumoylation of influenza A virus nucleoprotein is essential for intracellular trafficking and virus growth. J Virol 88:9379&#x2013;9390. doi:10.1128/JVI.00509-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00509-14</ArticleId><ArticleId IdType="pmc">PMC4136286</ArticleId><ArticleId IdType="pubmed">24920808</ArticleId></ArticleIdList></Reference><Reference><Citation>Izumiya Y, Ellison TJ, Yeh ET, Jung JU, Luciw PA, Kung HJ. 2005. Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification. J Virol 79:9912&#x2013;9925. doi:10.1128/JVI.79.15.9912-9925.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.15.9912-9925.2005</ArticleId><ArticleId IdType="pmc">PMC1181544</ArticleId><ArticleId IdType="pubmed">16014952</ArticleId></ArticleIdList></Reference><Reference><Citation>Izumiya Y, Kobayashi K, Kim KY, Pochampalli M, Izumiya C, Shevchenko B, Wang DH, Huerta SB, Martinez A, Campbell M, Kung HJ. 2013. Kaposi's sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivation. PLoS Pathog 9:e1003506. doi:10.1371/journal.ppat.1003506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003506</ArticleId><ArticleId IdType="pmc">PMC3749962</ArticleId><ArticleId IdType="pubmed">23990779</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcos-Villar L, Campagna M, Lopitz-Otsoa F, Gallego P, Gonzalez-Santamaria J, Gonzalez D, Rodriguez MS, Rivas C. 2011. Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2. J Gen Virol 92:188&#x2013;194. doi:10.1099/vir.0.024984-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.024984-0</ArticleId><ArticleId IdType="pubmed">20881090</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurer C, Berthoux L, Luban J. 2005. Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1. J Virol 79:910&#x2013;917. doi:10.1128/JVI.79.2.910-917.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.2.910-917.2005</ArticleId><ArticleId IdType="pmc">PMC538558</ArticleId><ArticleId IdType="pubmed">15613319</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamborlini A, Coiffic A, Beauclair G, Delelis O, Paris J, Koh Y, Magne F, Giron ML, Tobaly-Tapiero J, Deprez E, Emiliani S, Engelman A, de The H, Saib A. 2011. Impairment of human immunodeficiency virus type-1 integrase SUMOylation correlates with an early replication defect. J Biol Chem 286:21013&#x2013;21022. doi:10.1074/jbc.M110.189274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.189274</ArticleId><ArticleId IdType="pmc">PMC3121452</ArticleId><ArticleId IdType="pubmed">21454548</ArticleId></ArticleIdList></Reference><Reference><Citation>AbuBakar S, Chee HY, Al-Kobaisi MF, Xiaoshan J, Chua KB, Lam SK. 1999. Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res 61:1&#x2013;9. doi:10.1016/S0168-1702(99)00019-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-1702(99)00019-2</ArticleId><ArticleId IdType="pubmed">10426204</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26:91&#x2013;107. doi:10.1111/j.1574-6976.2002.tb00601.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SC, Chang LY, Wang YW, Chen YC, Weng KF, Shih SR, Shih HM. 2011. Sumoylation-promoted enterovirus 71 3C degradation correlates with a reduction in viral replication and cell apoptosis. J Biol Chem 286:31373&#x2013;31384. doi:10.1074/jbc.M111.254896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.254896</ArticleId><ArticleId IdType="pmc">PMC3173077</ArticleId><ArticleId IdType="pubmed">21784861</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Ke X, Wang M, He S, Li Q, Zheng C, Zhang Z, Liu Y, Wang H. 2013. Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome. J Virol 87:5645&#x2013;5656. doi:10.1128/JVI.02655-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02655-12</ArticleId><ArticleId IdType="pmc">PMC3648165</ArticleId><ArticleId IdType="pubmed">23468506</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzi M. 1950. Sampling variation of the fifty percent end-point, determined by the Reed-Muench (Behrens) method. Hum Biol 22:151&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">14778593</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Y, Trowbridge R, MacNaughton TB, Westaway EG, Shannon AD, Gowans EJ. 1996. Characterization of RNA synthesis during a one-step growth curve and of the replication mechanism of bovine viral diarrhoea virus. J Gen Virol 77:2729&#x2013;2736. doi:10.1099/0022-1317-77-11-2729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-77-11-2729</ArticleId><ArticleId IdType="pubmed">8922466</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Shimizu H, Nagata N, Ami Y, Suzaki Y, Sata T, Iwasaki T, Miyamura T. 2005. Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J Gen Virol 86:1391&#x2013;1401. doi:10.1099/vir.0.80784-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.80784-0</ArticleId><ArticleId IdType="pubmed">15831951</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Cao RY, Chen R, Mo L, Han JF, Wang X, Xu X, Jiang T, Deng YQ, Lyu K, Zhu SY, Qin ED, Tang R, Qin CF. 2013. Rational design of thermostable vaccines by engineered peptide-induced virus self-biomineralization under physiological conditions. Proc Natl Acad Sci U S A 110:7619&#x2013;7624. doi:10.1073/pnas.1300233110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1300233110</ArticleId><ArticleId IdType="pmc">PMC3651461</ArticleId><ArticleId IdType="pubmed">23589862</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Sahashi Y, Matsuo K, Asanuma H, Takahashi H, Iwasaki T, Suzuki Y, Aizawa C, Kurata T, Tamura S. 1998. Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. Vaccine 16:1544&#x2013;1549. doi:10.1016/S0264-410X(98)00043-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(98)00043-7</ArticleId><ArticleId IdType="pubmed">9711802</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Li H, Zhang Z, Meng J, Mao D, Bai B, Lu B, Mao P, Hu Q, Wang H. 2011. Enterovirus 71 2C protein inhibits TNF-alpha-mediated activation of NF-kappaB by suppressing IkappaB kinase beta phosphorylation. J Immunol 187:2202&#x2013;2212. doi:10.4049/jimmunol.1100285.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1100285</ArticleId><ArticleId IdType="pubmed">21810613</ArticleId></ArticleIdList></Reference><Reference><Citation>Terui Y, Saad N, Jia S, McKeon F, Yuan J. 2004. Dual role of sumoylation in the nuclear localization and transcriptional activation of NFAT1. J Biol Chem 279:28257&#x2013;28265. doi:10.1074/jbc.M403153200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M403153200</ArticleId><ArticleId IdType="pubmed">15117942</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamitani T, Nguyen HP, Kito K, Fukuda-Kamitani T, Yeh ET. 1998. Covalent modification of PML by the sentrin family of ubiquitin-like proteins. J Biol Chem 273:3117&#x2013;3120. doi:10.1074/jbc.273.6.3117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.6.3117</ArticleId><ArticleId IdType="pubmed">9452416</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J, Kang XL, Zhang S, Yeh ETH. 2007. SUMO-specific protease 1 is essential for stabilization of HIF1 alpha during hypoxia. Cell 131:584&#x2013;595. doi:10.1016/j.cell.2007.08.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.08.045</ArticleId><ArticleId IdType="pmc">PMC2128732</ArticleId><ArticleId IdType="pubmed">17981124</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasugi T, Howley PM. 1996. Identification of the structural and functional human homolog of the yeast ubiquitin conjugating enzyme UBC9. Nucleic Acids Res 24:2005&#x2013;2010. doi:10.1093/nar/24.11.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/24.11.2005</ArticleId><ArticleId IdType="pmc">PMC145898</ArticleId><ArticleId IdType="pubmed">8668529</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi Z, Fu J, Xiong Y, Tang H. 2010. SUMOylation of RIG-I positively regulates the type I interferon signaling. Protein Cell 1:275&#x2013;283. doi:10.1007/s13238-010-0030-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-010-0030-1</ArticleId><ArticleId IdType="pmc">PMC4875083</ArticleId><ArticleId IdType="pubmed">21203974</ArticleId></ArticleIdList></Reference><Reference><Citation>Ran Y, Liu TT, Zhou Q, Li S, Mao AP, Li Y, Liu LJ, Cheng JK, Shu HB. 2011. SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation. J Mol Cell Biol 3:283&#x2013;292. doi:10.1093/jmcb/mjr020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjr020</ArticleId><ArticleId IdType="pubmed">22028379</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H, Zhang Z, Zheng Z, Ke X, Zhang X, Li Q, Liu Y, Bai B, Mao P, Hu Q, Wang H. 2013. Human bocavirus VP2 upregulates IFN-beta pathway by inhibiting ring finger protein 125-mediated ubiquitination of retinoic acid-inducible gene-I. J Immunol 191:660&#x2013;669. doi:10.4049/jimmunol.1202933.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1202933</ArticleId><ArticleId IdType="pubmed">23772026</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong P, Campagnola G, Peersen OB. 2009. A quantitative stopped-flow fluorescence assay for measuring polymerase elongation rates. Anal Biochem 391:45&#x2013;55. doi:10.1016/j.ab.2009.04.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ab.2009.04.035</ArticleId><ArticleId IdType="pmc">PMC2713312</ArticleId><ArticleId IdType="pubmed">19406094</ArticleId></ArticleIdList></Reference><Reference><Citation>Gohara DW, Ha CS, Kumar S, Ghosh B, Arnold JJ, Wisniewski TJ, Cameron CE. 1999. Production of &#x201c;authentic&#x201d; poliovirus RNA-dependent RNA polymerase (3D(pol)) by ubiquitin-protease-mediated cleavage in Escherichia coli. Protein Expr Purif 17:128&#x2013;138. doi:10.1006/prep.1999.1100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/prep.1999.1100</ArticleId><ArticleId IdType="pubmed">10497078</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber AR, Schuermann D, Schar P. 2014. Versatile recombinant SUMOylation system for the production of SUMO-modified protein. PLoS One 9:e102157. doi:10.1371/journal.pone.0102157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0102157</ArticleId><ArticleId IdType="pmc">PMC4090232</ArticleId><ArticleId IdType="pubmed">25007328</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu B, Gong P. 2016. Structural basis of viral RNA-dependent RNA polymerase catalysis and translocation. Proc Natl Acad Sci U S A 113:E4005&#x2013;E4014. doi:10.1073/pnas.1602591113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1602591113</ArticleId><ArticleId IdType="pmc">PMC4948327</ArticleId><ArticleId IdType="pubmed">27339134</ArticleId></ArticleIdList></Reference><Reference><Citation>Batey RT, Kieft JS. 2007. Improved native affinity purification of RNA. RNA 13:1384&#x2013;1389. doi:10.1261/rna.528007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.528007</ArticleId><ArticleId IdType="pmc">PMC1924900</ArticleId><ArticleId IdType="pubmed">17548432</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Lu G, Zhang B, Gong P. 2015. Perturbation in the conserved methyltransferase-polymerase interface of flavivirus NS5 differentially affects polymerase initiation and elongation. J Virol 89:249&#x2013;261. doi:10.1128/JVI.02085-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02085-14</ArticleId><ArticleId IdType="pmc">PMC4301151</ArticleId><ArticleId IdType="pubmed">25320292</ArticleId></ArticleIdList></Reference><Reference><Citation>Campagnola G, Weygandt M, Scoggin K, Peersen O. 2008. Crystal structure of coxsackievirus B3 3Dpol highlights the functional importance of residue 5 in picornavirus polymerases. J Virol 82:9458&#x2013;9464. doi:10.1128/JVI.00647-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00647-08</ArticleId><ArticleId IdType="pmc">PMC2546958</ArticleId><ArticleId IdType="pubmed">18632862</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao S, Wang W, Chen C, Chang Y, Wu Y, Wang Y, Wang S, Nesvizhskii AI, Chen Y, Hong T, Yang P. 2015. Analysis of protein stability by the cycloheximide chase assay. Bio Protoc 5:e1374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5659619</ArticleId><ArticleId IdType="pubmed">29082276</ArticleId></ArticleIdList></Reference><Reference><Citation>Saitoh H, Hinchey J. 2000. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J Biol Chem 275:6252&#x2013;6258. doi:10.1074/jbc.275.9.6252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.275.9.6252</ArticleId><ArticleId IdType="pubmed">10692421</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimmer P, Schreiner S, Dobner T. 2012. Human pathogens and the host cell SUMOylation system. J Virol 86:642&#x2013;654. doi:10.1128/JVI.06227-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06227-11</ArticleId><ArticleId IdType="pmc">PMC3255802</ArticleId><ArticleId IdType="pubmed">22072786</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q, Xie Y, Zheng Y, Jiang S, Liu W, Mu W, Liu Z, Zhao Y, Xue Y, Ren J. 2014. GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs. Nucleic Acids Res 42:W325&#x2013;W330. doi:10.1093/nar/gku383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku383</ArticleId><ArticleId IdType="pmc">PMC4086084</ArticleId><ArticleId IdType="pubmed">24880689</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong P, Peersen OB. 2010. Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase. Proc Natl Acad Sci U S A 107:22505&#x2013;22510. doi:10.1073/pnas.1007626107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1007626107</ArticleId><ArticleId IdType="pmc">PMC3012486</ArticleId><ArticleId IdType="pubmed">21148772</ArticleId></ArticleIdList></Reference><Reference><Citation>Si XN, Gao G, Wong J, Wang YH, Zhang JC, Luo HL. 2008. Ubiquitination is required for effective replication of coxsackievirus B3. PLoS One 3:e2585. doi:10.1371/journal.pone.0002585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0002585</ArticleId><ArticleId IdType="pmc">PMC2440516</ArticleId><ArticleId IdType="pubmed">18612413</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Qin Y, Wu H, Chen Y, Wu S, Si X, Wang H, Wang T, Zhong X, Zhai X, Tong L, Pan B, Zhang F, Zhong Z, Wang Y, Zhao W. 2015. Pyrrolidine dithiocarbamate inhibits enterovirus 71 replication by down-regulating ubiquitin-proteasome system. Virus Res 195:207&#x2013;216. doi:10.1016/j.virusres.2014.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.10.012</ArticleId><ArticleId IdType="pubmed">25456405</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom J, Pagano M. 2005. Experimental tests to definitively determine ubiquitylation of a substrate. Methods Enzymol 399:249&#x2013;266. doi:10.1016/S0076-6879(05)99017-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0076-6879(05)99017-4</ArticleId><ArticleId IdType="pubmed">16338361</ArticleId></ArticleIdList></Reference><Reference><Citation>Dammer EB, Na CH, Xu P, Seyfried NT, Duong DM, Cheng D, Gearing M, Rees H, Lah JJ, Levey AI, Rush J, Peng J. 2011. Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease. J Biol Chem 286:10457&#x2013;10465. doi:10.1074/jbc.M110.149633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.149633</ArticleId><ArticleId IdType="pmc">PMC3060499</ArticleId><ArticleId IdType="pubmed">21278249</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallette FA, Richard S. 2012. K48-linked ubiquitination and protein degradation regulate 53BP1 recruitment at DNA damage sites. Cell Res 22:1221&#x2013;1223. doi:10.1038/cr.2012.58.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2012.58</ArticleId><ArticleId IdType="pmc">PMC3411168</ArticleId><ArticleId IdType="pubmed">22491476</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes R, Guerra-Sa R, Arruda E. 2010. Coxsackievirus B5 induced apoptosis of HeLa cells: effects on p53 and SUMO. Virology 396:256&#x2013;263. doi:10.1016/j.virol.2009.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.10.005</ArticleId><ArticleId IdType="pubmed">19906394</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong RY, Wang AM. 2013. SCE1, the SUMO-conjugating enzyme in plants that interacts with NIb, the RNA-dependent RNA polymerase of turnip mosaic virus, is required for viral infection. J Virol 87:4704&#x2013;4715. doi:10.1128/JVI.02828-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02828-12</ArticleId><ArticleId IdType="pmc">PMC3624346</ArticleId><ArticleId IdType="pubmed">23365455</ArticleId></ArticleIdList></Reference><Reference><Citation>Su CI, Tseng CH, Yu CY, Lai MM. 2016. SUMO modification stabilizes dengue virus nonstructural protein 5 to support virus replication. J Virol 90:4308&#x2013;4319. doi:10.1128/JVI.00223-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00223-16</ArticleId><ArticleId IdType="pmc">PMC4836324</ArticleId><ArticleId IdType="pubmed">26889037</ArticleId></ArticleIdList></Reference><Reference><Citation>Miteva M, Keusekotten K, Hofmann K, Praefcke GJK, Dohmen RJ. 2010. SUMOylation as a signal for polyubiquitylation and proteasomal degradation, p 195&#x2013;215. In Groettrup M. (ed), Conjugation and deconjugation of ubiquitin family modifiers. Landes Bioscience, Austin, TX.</Citation><ArticleIdList><ArticleId IdType="pubmed">21222284</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Santamaria J, Campagna M, Garcia MA, Marcos-Villar L, Gonzalez D, Gallego P, Lopitz-Otsoa F, Guerra S, Rodriguez MS, Esteban M, Rivas C. 2011. Regulation of vaccinia virus E3 protein by small ubiquitin-like modifier proteins. J Virol 85:12890&#x2013;12900. doi:10.1128/JVI.05628-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05628-11</ArticleId><ArticleId IdType="pmc">PMC3233166</ArticleId><ArticleId IdType="pubmed">21957283</ArticleId></ArticleIdList></Reference><Reference><Citation>Klenk C, Humrich J, Quitterer U, Lohse MJ. 2006. SUMO-1 controls the protein stability and the biological function of phosducin. J Biol Chem 281:8357&#x2013;8364. doi:10.1074/jbc.M513703200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M513703200</ArticleId><ArticleId IdType="pubmed">16421094</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Xu M, Scotti E, Chen ZJJ, Tontonoz P. 2013. Both K63 and K48 ubiquitin linkages signal lysosomal degradation of the LDL receptor. J Lipid Res 54:1410&#x2013;1420. doi:10.1194/jlr.M035774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M035774</ArticleId><ArticleId IdType="pmc">PMC3653405</ArticleId><ArticleId IdType="pubmed">23419260</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruenn JA. 2003. A structural and primary sequence comparison of the viral RNA-dependent RNA polymerases. Nucleic Acids Res 31:1821&#x2013;1829. doi:10.1093/nar/gkg277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkg277</ArticleId><ArticleId IdType="pmc">PMC152793</ArticleId><ArticleId IdType="pubmed">12654997</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Lou Z, Miao Y, Yu Y, Dong H, Peng W, Bartlam M, Li X, Rao Z. 2010. Structures of EV71 RNA-dependent RNA polymerase in complex with substrate and analogue provide a drug target against the hand-foot-and-mouth disease pandemic in China. Protein Cell 1:491&#x2013;500. doi:10.1007/s13238-010-0061-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-010-0061-7</ArticleId><ArticleId IdType="pmc">PMC4875138</ArticleId><ArticleId IdType="pubmed">21203964</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerkvliet J, Papke L, Rodriguez M. 2011. Antiviral effects of a transgenic RNA-dependent RNA polymerase. J Virol 85:621&#x2013;625. doi:10.1128/JVI.01626-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01626-10</ArticleId><ArticleId IdType="pmc">PMC3014166</ArticleId><ArticleId IdType="pubmed">20962089</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi AG, Wong J, Marchant D, Luo H. 2013. The ubiquitin-proteasome system in positive-strand RNA virus infection. Rev Med Virol 23:85&#x2013;96. doi:10.1002/rmv.1725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1725</ArticleId><ArticleId IdType="pmc">PMC7169083</ArticleId><ArticleId IdType="pubmed">22782620</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>